dc.contributor.author | Reitsamer, Roland | en |
dc.contributor.author | Fastner, Gerd | en |
dc.contributor.author | Kopp, Michael | en |
dc.contributor.author | Menzel, Christian | en |
dc.contributor.author | Sedlmayer, Felix | en |
dc.date.accessioned | 2015-02-23T22:29:59Z | |
dc.date.available | 2015-02-23T22:29:59Z | |
dc.date.issued | 2015-02-24 | |
dc.identifier.uri | http://hdl.handle.net/11400/6817 | |
dc.rights | Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.source | http://www.thelancet.com/ | el |
dc.subject | Cancer | |
dc.subject | Καρκίνος | |
dc.title | Intraoperative radiotherapy for early breast cancer | en |
heal.type | journalArticle | |
heal.classification | Pharmacology | |
heal.classification | Radiology, Medical | |
heal.classification | Φαρμακολογία | |
heal.classification | Ακτινολογία, Ιατρική | |
heal.classificationURI | http://skos.um.es/unescothes/C02967 | |
heal.classificationURI | http://id.loc.gov/authorities/subjects/sh85110777 | |
heal.classificationURI | **N/A**-Φαρμακολογία | |
heal.classificationURI | **N/A**-Ραδιοθεραπεία | |
heal.keywordURI | http://skos.um.es/unescothes/C00499 | |
heal.identifier.secondary | DOI: http://dx.doi.org/10.1016/S0140-6736(10)61529-2 | |
heal.language | en | |
heal.access | free | |
heal.recordProvider | Τ.Ε.Ι. Αθήνας. Σχολή Επαγγελμάτων Υγείας και Πρόνοιας. Τμήμα Ραδιολογίας και Ακτινολογίας. | el |
heal.publicationDate | 2010 | |
heal.bibliographicCitation | Reitsamer, R., Fastner, G., Kopp, M., Menzel, C. and Sedlmayer, F. (October 2010). Intraoperative radiotherapy for early breast cancer. The Lancet. 376(9747). p. 1141. Elsevier Ltd: 2010. Available from: http://www.thelancet.com/ | en |
heal.abstract | Jayant Vaidya and colleagues (July 10, p 91)1 suggest that a single dose of targeted intraoperative radiotherapy (TARGIT) should be considered as an alternative to external-beam radiotherapy delivered over several weeks for selected patients with breast cancer. We consider the results of this trial preliminary and immature since the follow-up is much too short to draw any conclusions about local recurrence rates. | en |
heal.publisher | Elsevier Ltd | el |
heal.journalName | The Lancet | en |
heal.journalType | peer-reviewed | |
heal.fullTextAvailability | true |
Οι παρακάτω άδειες σχετίζονται με αυτό το τεκμήριο: